Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response study of OPC-12759 ophthalmic suspension
jRCT2080220040Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rebamipide in dry eye syndrome (DED), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
rebamipide
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2080220040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220040.